Lucius Gefitinib – Buy Online
Gefitinib was first approved by the U.S. FDA in 2015 for the treatment of patients with non-small cell lung cancer with specific EGFR mutations.
View Product
Gefitinib may improve prognosis in patients with relapsed/refractory FLT3-mutant acute myeloid leukemia after hematopoietic stem cell transplantation – Targeted Oncology
Gefitinib may improve prognosis in patients with relapsed/refractory FLT3-mutant acute myeloid leukemia after hematopoietic stem cell transplantation.
该文章暂未提取到完整正文，已从资讯列表和商品关联资讯中自动隐藏。你可以返回文章列表继续浏览其他内容。
Products Mentioned in This Article
These products were automatically matched from the article title, summary, and full content.
Frequently Asked Questions
Which products are related to this article?
The system matched these relevant products from the article content: Lucius Gefitinib – Buy Online.
How can I view the medicines discussed in this article?
Use the related product cards below the article to review available specifications, prices, product information, and reviews.
Does this article replace advice from a doctor or pharmacist?
No. This content is for general information and health education only. Follow the prescription and individual guidance provided by qualified healthcare professionals.
